23 November 2023
23 November 2023
The project has been built using donations from individuals and corporations.
The specialised unit is designed to treat babies born at 30 weeks or earlier or weighing less than 1.25kg.
The 500-bed facility will offer paediatrics, obstetrics, gynaecology and general surgery services among others.
The facility aims to increase surgical activity and minimise the impact of unscheduled care on elective treatments.
The new clinic is said to serve as a hub to bring quality, patient-centric care to underserved populations.
These clinics will operate seven days a week, offering walk-in care with fully bulk-billed services.
The expansion nearly triples the existing facility’s capacity and helps it handle up to 60,000 patient visits annually.
Laudio's platform automates repetitive tasks and provides daily recommendations to help frontline leaders.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.
Give your business an edge with our leading industry insights.
